WSJ Says FTC Increasingly Unlikely to Block Deal Between Medco (MHS), Express Scripts (ESRX)

Go back to WSJ Says FTC Increasingly Unlikely to Block Deal Between Medco (MHS), Express Scripts (ESRX)